Ahlskog JE - Search Results

1

Orthostatic myoclonus associated with Caspr2 antibodies.

van Gerpen JA, Ahlskog JE, Chen R, Fung VS, Hallett M, Gövert F, Deuschl G, Leypoldt F. van Gerpen JA, et al. Among authors: ahlskog je. Neurology. 2016 Sep 13;87(11):1187-8. doi: 10.1212/WNL.0000000000003140. Neurology. 2016. PMID: 27621382 No abstract available.

2

Guamanian neurodegenerative disease: investigation of the calcium metabolism/heavy metal hypothesis.

Ahlskog JE, Waring SC, Kurland LT, Petersen RC, Moyer TP, Harmsen WS, Maraganore DM, O'Brien PC, Esteban-Santillan C, Bush V. Ahlskog JE, et al. Neurology. 1995 Jul;45(7):1340-4. doi: 10.1212/wnl.45.7.1340. Neurology. 1995. PMID: 7617195

3

Guamanian neurodegenerative disease: are diabetes mellitus and altered humoral immunity clues to pathogenesis?

Ahlskog JE, Petersen RC, Waring SC, Esteban-Santillan C, Craig UK, Maraganore DM, Lennon VA, Kurland LT. Ahlskog JE, et al. Neurology. 1997 May;48(5):1356-62. doi: 10.1212/wnl.48.5.1356. Neurology. 1997. PMID: 9153473

4

Utility of an EMG mapping study in treating cervical dystonia.

Van Gerpen JA, Matsumoto JY, Ahlskog JE, Maraganore DM, McManis PG. Van Gerpen JA, et al. Among authors: ahlskog je. Muscle Nerve. 2000 Nov;23(11):1752-6. doi: 10.1002/1097-4598(200011)23:11<1752::aid-mus12>3.0.co;2-u. Muscle Nerve. 2000. PMID: 11054755 Clinical Trial.

5

Selegiline and mortality in subjects with Parkinson's disease: a longitudinal community study.

Van Gerpen JA, Ahlskog JE. Van Gerpen JA, et al. Among authors: ahlskog je. Neurology. 2001 Jul 24;57(2):368-9; author reply 369-70. doi: 10.1212/wnl.57.2.368-a. Neurology. 2001. PMID: 11468339 No abstract available.

6

Nonfatal cancer preceding Parkinson's disease: a case-control study.

Elbaz A, Peterson BJ, Yang P, Van Gerpen JA, Bower JH, Maraganore DM, McDonnell SK, Ahlskog JE, Rocca WA. Elbaz A, et al. Among authors: ahlskog je. Epidemiology. 2002 Mar;13(2):157-64. doi: 10.1097/00001648-200203000-00010. Epidemiology. 2002. PMID: 11880756

7

Slowing Parkinson's disease progression: recent dopamine agonist trials.

Ahlskog JE. Ahlskog JE. Neurology. 2003 Feb 11;60(3):381-9. doi: 10.1212/01.wnl.0000044047.58984.2f. Neurology. 2003. PMID: 12580184 Review.

8

Synucleinopathy pathology and REM sleep behavior disorder plus dementia or parkinsonism.

Boeve BF, Silber MH, Parisi JE, Dickson DW, Ferman TJ, Benarroch EE, Schmeichel AM, Smith GE, Petersen RC, Ahlskog JE, Matsumoto JY, Knopman DS, Schenck CH, Mahowald MW. Boeve BF, et al. Among authors: ahlskog je. Neurology. 2003 Jul 8;61(1):40-5. doi: 10.1212/01.wnl.0000073619.94467.b0. Neurology. 2003. PMID: 12847154

9

Progressive supranuclear palsy phenotype secondary to CADASIL.

Van Gerpen JA, Ahlskog JE, Petty GW. Van Gerpen JA, et al. Among authors: ahlskog je. Parkinsonism Relat Disord. 2003 Aug;9(6):367-9. doi: 10.1016/s1353-8020(02)00146-3. Parkinsonism Relat Disord. 2003. PMID: 12853237

10

Levodopa-dyskinesia incidence by age of Parkinson's disease onset.

Kumar N, Van Gerpen JA, Bower JH, Ahlskog JE. Kumar N, et al. Among authors: ahlskog je. Mov Disord. 2005 Mar;20(3):342-4. doi: 10.1002/mds.20360. Mov Disord. 2005. PMID: 15580606

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

292 results

Search Page

Filters